Company / Tangible Book Value per Share
Dexcom Tangible Book Value per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Tangible Book Value per Share
$7.07
FY2025
5-year range
$3.93 / $20.97
FY2021-FY2025
Trend
+32.9%
vs FY2024
Sector context
#63 of 158
Health Care
What the data says
At $7.07, Dexcom's tangible book value per share ranks #63 of 158 in the Health Care sector. Tangible Book Value per Share has increased for 3 consecutive years, from $3.93 in FY2022 to $7.07 in FY2025.
Based on SEC 10-K filings.
7.07 in FY2025 with a 5-year CAGR of -15.0%.
Improved from $5.30 to $7.07 over the past 2 years.
Health Care sector context is included.
Tangible Book Value per Share over time
Growth rates
- 3-Year CAGR
- +21.6%
- 5-Year CAGR
- -15.0%
- 10-Year CAGR
- -
Sector benchmark
#63 of 158 in Health CareTop 40% of 158This company $7.07 Sector average $18.47
▼
-61.7% below sector average
Key checks
Key Insights
- Dexcom's tangible book value per share has grown for 3 consecutive years.
- In FY2025, tangible book value per share increased 32.9% year-over-year.
- Ranks #63 out of 158 companies in the Health Care sector.
- Peak tangible book value per share was recorded in FY2021.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
- Strong return on equity: 26.4%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Tangible Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $7.07 | +32.9% |
| FY2024 | $5.32 | +0.4% |
| FY2023 | $5.30 | +34.8% |
| FY2022 | $3.93 | -81.2% |
| FY2021 | $20.97 | +31.5% |
| FY2020 | $15.95 | +69.1% |
| FY2019 | $9.43 | +27.3% |
| FY2018 | $7.41 | +199.8% |
| FY2017 | $2.47 | +56.7% |
| FY2016 | $1.58 | +51.7% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026